A research paper on AI-driven drug discovery by SAKURA internet and COGNANO was accepted by NeurIPS 2024, a prestigious AI conference

Contributed by: Business Wire

Images

Overview of Research (Graphic: Business Wire)
Overview of Research (Graphic: Business Wire)
Business Wire embedded0

Tags

Research
Pharmaceutical
Other Natural Resources
Technology
Infectious Diseases
Natural Resources
Artificial Intelligence
Health Technology
Science
COVID-19
Biotechnology
Health
AI, pharmaceuticals

More Like This

PR Newswire associated0

Tsingke Highlights AI-Driven CLDN18.2 Antibody Discovery at AIS 2026

PR Newswire associated0

Viva Biotech Accelerates AI-Driven Drug Discovery and Advance the 'Lab-in-the-Loop' with NVIDIA

PR Newswire associated0

Viva Biotech Launches the AI-Driven Drug Discovery Platform, Transforming New Drug R&D Logic, Enabling One-Stop Innovative Drug Discovery

PR Newswire associated0

Cognizant Unveils Advanced Artificial Intelligence Lab to Accelerate AI Research and Innovation

PR Newswire associated0

NJ Bio, Inc. and Ajinomoto Bio‑Pharma Services Enter into Collaboration to Strengthen Support for Antibody-Drug Conjugate Development

Business Wire logo

Canada-UK Collaboration Developing AI-powered Bioreactors to Revolutionise Biopharmaceutical Manufacturing

Business Wire logo

Unlocking the Power of Large Language Models: From Neural Network Basics to Biopharma Industry Transformation

PR Newswire associated0

Merck Launches First Ever AI Solution to Integrate Drug Discovery and Synthesis